Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. Commonly employed in research settings for designing enzyme inhibitors, especially targeting serine proteases. Also utilized in the preparation of boron-containing compounds for potential applications in targeted cancer therapies and diagnostic agents.